Page last updated: 2024-09-05

ngd 94-1 and raclopride

ngd 94-1 has been researched along with raclopride in 1 studies

Compound Research Comparison

Studies
(ngd 94-1)
Trials
(ngd 94-1)
Recent Studies (post-2010)
(ngd 94-1)
Studies
(raclopride)
Trials
(raclopride)
Recent Studies (post-2010) (raclopride)
15041,802132419

Protein Interaction Comparison

ProteinTaxonomyngd 94-1 (IC50)raclopride (IC50)
D(2) dopamine receptorHomo sapiens (human)0.052
D(2) dopamine receptorMus musculus (house mouse)0.032
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0279

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gallagher, DW; McInerney, S; Primus, RJ; Shaw, K; Tallman, JF; Thurkauf, A; Xu, J; Yevich, E1

Other Studies

1 other study(ies) available for ngd 94-1 and raclopride

ArticleYear
II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 282, Issue:2

    Topics: Animals; Autoradiography; Brain; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Imidazoles; Male; Pyrimidines; Raclopride; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D4; Salicylamides; Tetrahydronaphthalenes; Tritium

1997
chemdatabank.com